Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02640 | 34299189 | Int J Mol Sci | Current Options and Future Directions for NAFLD and NASH Treatment. | 2021 | Details |
| A02643 | 34298930 | Int J Mol Sci | Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts. | 2021 | Details |
| A02653 | 34297426 | Hepatology | Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway. | 2021 | Details |
| A02658 | 34294937 | Pathologica | Pathology of non-alcoholic fatty liver disease. | 2021 | Details |
| A02662 | 34294375 | J Pharmacol Sci | Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways. | 2021 | Details |
| A02665 | 34292604 | Hepatology | Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. | 2021 | Details |
| A02668 | 34291454 | Eur J Clin Invest | Omega-3 phospholipids and obesity-associated NAFLD: Potential mechanisms and therapeutic perspectives. | 2021 | Details |
| A02670 | 34290320 | Sci Rep | AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. | 2021 | Details |
| A02674 | 34289506 | Semin Liver Dis | Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02697 | 34279051 | Obes Rev | Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease. | 2021 | Details |
| A02708 | 34277236 | Cureus | The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A02709 | 34276380 | Front Pharmacol | Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1. | 2021 | Details |
| A02710 | 34276360 | Front Pharmacol | Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. | 2021 | Details |
| A02711 | 34276221 | Diabetes Metab Syndr Obes | Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02718 | 34275345 | Int J Immunopathol Pharmacol | Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach. | 2022 | Details |
| A02726 | 34272738 | Hepatology | The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1. | 2021 | Details |
| A02733 | 34267042 | Curr Opin Infect Dis | The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. | 2021 | Details |
| A02744 | 34262716 | Food Sci Nutr | Effect of garlic powder supplementation on blood pressure and hs-C-reactive protein among nonalcoholic fatty liver disease patients: A randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A02766 | 34251802 | J Agric Food Chem | Oleanolic Acid Targets the Gut-Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis. | 2021 | Details |
| A02777 | 34245170 | J Food Biochem | Ziziphus spina-christi (L.) fortified with Camellia sinensis mediates apoptosis, Notch-1 signaling, and mitigates obesity-induced non-alcoholic fatty liver. | 2021 | Details |
| A02778 | 34244048 | Nutr Metab Cardiovasc Dis | Early identification of metabolic syndrome risk: A review of reviews and proposal for defining pre-metabolic syndrome status. | 2021 | Details |
| A02779 | 34243681 | Pharm Biol | Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-κB p65 pathway. | 2021 | Details |
| A02784 | 34242656 | Am J Pathol | Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation. | 2021 | Details |
| A02790 | 34239622 | Dis Markers | Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02794 | 34238176 | Curr Mol Pharmacol | The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylaminofluorene- Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling. | 2022 | Details |
| A02796 | 34236487 | Semin Immunopathol | Role of bile acids in inflammatory liver diseases. | 2021 | Details |
| A02803 | 34234491 | Diabetes Metab Syndr Obes | Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients. | 2021 | Details |
| A02823 | 34229251 | Biomed Pharmacother | Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways. | 2021 | Details |
| A02836 | 34224858 | Pharmacol Res | Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. | 2021 | Details |
| A02840 | 34222711 | Curr Opin Endocr Metab Res | Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progression. | 2021 | Details |
| A02845 | 34221404 | SAGE Open Med Case Rep | Ibuprofen-associated minimal change disease and acute interstitial nephritis with possibly linked membranous glomerulonephritis. | 2021 | Details |
| A02846 | 34221262 | Gastroenterol Hepatol Bed Bench | Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients? | 2021 | Details |
| A02852 | 34219227 | Eur J Clin Invest | The role of RIPK3 in liver mitochondria bioenergetics and function. | 2021 | Details |
| A02854 | 34218773 | Curr Pharm Des | Vanillic Acid and Non-Alcoholic Fatty Liver Disease: A Focus on AMPK in Adipose and Liver Tissues. | 2021 | Details |
| A02860 | 34213784 | Phytother Res | Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways. | 2021 | Details |
| A02868 | 34211711 | SAGE Open Med | Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. | 2021 | Details |
| A02871 | 34211157 | Nat Rev Gastroenterol Hepatol | New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. | 2021 | Details |
| A02878 | 34208774 | Int J Mol Sci | Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02881 | 34206629 | Nutrients | Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring. | 2021 | Details |
| A02890 | 34204571 | Biomedicines | The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases. | 2021 | Details |
| A02894 | 34204055 | Nutrients | Matcha Green Tea Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating Lipid Metabolism and Inflammatory Responses. | 2021 | Details |
| A02895 | 34203484 | Int J Mol Sci | Fructose and the Liver. | 2021 | Details |
| A02898 | 34203178 | Int J Mol Sci | Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. | 2021 | Details |
| A02909 | 34200685 | Metabolites | Metabolomic Study of High-Fat Diet-Induced Obese (DIO) and DIO Plus CCl4-Induced NASH Mice and the Effect of Obeticholic Acid. | 2021 | Details |
| A02915 | 34199317 | Int J Mol Sci | Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH. | 2021 | Details |
| A02918 | 34199237 | Diagnostics (Basel) | Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study. | 2021 | Details |
| A02932 | 34192596 | Life Sci | Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice. | 2021 | Details |
| A02953 | 34186207 | Free Radic Biol Med | Gut inflammation exacerbates high-fat diet induced steatosis by suppressing VLDL-TG secretion through HNF4α pathway. | 2021 | Details |
| A02955 | 34185201 | Inflammopharmacology | Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD. | 2021 | Details |
| A02965 | 34182909 | Curr Vasc Pharmacol | Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers. | 2021 | Details |
| A02976 | 34176536 | Nutr Res Rev | Carbohydrates deteriorate fatty liver by activating the inflammatory response. | 2021 | Details |
| A02977 | 34176456 | Curr Pharm Des | Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02980 | 34175381 | Toxicology | Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. | 2021 | Details |
| A02992 | 34171492 | Pharmacol Res | Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview. | 2021 | Details |
| A03003 | 34168408 | World J Gastroenterol | COVID-19 and pediatric fatty liver disease: Is there interplay? | 2021 | Details |
| A03006 | 34167531 | BMC Surg | Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study. | 2021 | Details |
| A03027 | 34159442 | J Gastroenterol | STING and liver disease. | 2021 | Details |
| A03029 | 34159161 | Hepatobiliary Surg Nutr | Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions. | 2021 | Details |
| A03040 | 34155798 | Liver Int | Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity? | 2021 | Details |
| A03043 | 34155789 | Liver Int | COVID-19 and the liver - Lessons learned. | 2021 | Details |
| A03071 | 34142329 | Fish Physiol Biochem | Metabolism and antioxidation regulation of total flavanones from Sedum sarmentosum Bunge against high-fat diet-induced fatty liver disease in Nile tilapia (Oreochromis niloticus). | 2021 | Details |
| A03081 | 34138765 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with a higher incidence of coeliac disease. | 2022 | Details |
| A03131 | 34118476 | Mol Metab | Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH. | 2021 | Details |
| A03134 | 34118321 | Gastroenterol Hepatol | Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. | 2021 | Details |
| A03139 | 34116355 | Biochem Biophys Res Commun | Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma. | 2021 | Details |
| A03147 | 34113839 | JHEP Rep | Evaluating causality of cellular senescence in non-alcoholic fatty liver disease. | 2021 | Details |
| A03148 | 34113260 | Front Physiol | Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders. | 2021 | Details |
| A03161 | 34107545 | Semin Liver Dis | Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. | 2021 | Details |
| A03167 | 34106414 | Cell Biochem Biophys | Thermally Oxidized Coconut Oil as Fat Source in High-Fat Diet Induces Hepatic Fibrosis in Diabetic Rat Model. | 2021 | Details |
| A03173 | 34101924 | Biofactors | alpha-Tocopherol supplementation reduces inflammation and apoptosis in high cholesterol mediated nonalcoholic steatohepatitis. | 2021 | Details |
| A03176 | 34099626 | Nutr Diabetes | Aging mitigates the severity of obesity-associated metabolic sequelae in a gender independent manner. | 2021 | Details |
| A03184 | 34096467 | Bioengineered | The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis. | 2021 | Details |
| A03185 | 34096005 | Methods Mol Biol | Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A03188 | 34095305 | Biomed Res Int | A Combination of Geniposide and Chlorogenic Acid Combination Ameliorates Nonalcoholic Steatohepatitis in Mice by Inhibiting Kupffer Cell Activation. | 2021 | Details |
| A03190 | 34095164 | Front Med (Lausanne) | Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients. | 2021 | Details |
| A03191 | 34095107 | Front Cell Dev Biol | Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet. | 2021 | Details |
| A03196 | 34093184 | Front Pharmacol | Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation. | 2021 | Details |
| A03206 | 34090052 | Biomed Pharmacother | Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model. | 2021 | Details |
| A03209 | 34088912 | Sci Rep | A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models. | 2021 | Details |
| A03217 | 34083664 | Sci Rep | Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH. | 2021 | Details |
| A03242 | 34074100 | Vnitr Lek | Rheumatoid arthritis and metabolic disorders. | 2021 | Details |
| A03248 | 34072586 | Int J Mol Sci | One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver. | 2021 | Details |
| A03256 | 34069176 | Life (Basel) | Kaempferol-3-O-Glucuronide Ameliorates Non-Alcoholic Steatohepatitis in High-Cholesterol-Diet-Induced Larval Zebrafish and HepG2 Cell Models via Regulating Oxidation Stress. | 2021 | Details |
| A03260 | 34067931 | Int J Mol Sci | Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights. | 2021 | Details |
| A03268 | 34065241 | Biology (Basel) | Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. | 2021 | Details |
| A03278 | 34063865 | Metabolites | The Role of AKR1B10 in Physiology and Pathophysiology. | 2021 | Details |
| A03293 | 34058074 | FEBS J | Role of Mcpip1 in obesity-induced hepatic steatosis as determined by myeloid and liver-specific conditional knockouts. | 2021 | Details |
| A03294 | 34057877 | Expert Rev Clin Immunol | The pathogenic oral-gut-liver axis: new understandings and clinical implications. | 2021 | Details |
| A03309 | 34050551 | J Gastroenterol Hepatol | Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease. | 2021 | Details |
| A03318 | 34047129 | Zhongguo Zhong Yao Za Zhi | [Effect of total saponins from Panax japonicus on non-alcoholic steatohepatitis by regulating autophagy]. | 2021 | Details |
| A03325 | 34043691 | PLoS One | Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. | 2021 | Details |
| A03326 | 34043630 | PLoS One | Association between toothbrushing and non-alcoholic fatty liver disease. | 2021 | Details |
| A03333 | 34040411 | J Inflamm Res | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice. | 2021 | Details |
| A03336 | 34037463 | Am J Physiol Gastrointest Liver Physiol | Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications. | 2021 | Details |
| A03354 | 34031327 | Med J Malaysia | Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. | 2021 | Details |
| A03375 | 34025683 | Front Immunol | Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. | 2021 | Details |
| A03378 | 34025071 | World J Gastroenterol | Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. | 2021 | Details |
| A03395 | 34017133 | Nat Med | XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. | 2021 | Details |
| A03400 | 34015596 | Int Immunopharmacol | Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies. | 2021 | Details |
| A03417 | 34007325 | Exp Ther Med | Maternal obesity accelerated non-alcoholic fatty liver disease in offspring mice by reducing autophagy. | 2021 | Details |